Logistic regression was used to determine the association between candidate risk factors and treatment‐induced cardiotoxicity. Results: Among 573 patients, 92 (16%) developed treatment‐induced cardiotoxicity.
Book Title: Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction
Author:
Published on 2015 by
ISBN: /
Total Page:
Book Category:
Book is About: Breast Cancer Treatment
Get Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction eBook
Abstract : Background: Adjuvant trastuzumab is a highly effective targeted treatment that improves survival for patients with HER2‐positive breast cancer. However, trastuzumab interruption is recommended for patients who develop treatment‐induced cardiotoxicity (i.e., decline in left ventricular ejection fraction [LVEF], with or without symptoms) and can lead to an incomplete course of treatment. We studied the cardiac safety of continuous trastuzumab therapy among patients with asymptomatic declines in LVEF. Methods: We retrospectively evaluated patients with HER2‐positive breast cancer treated with adjuvant trastuzumab at our institution between 2005 and 2010. Treatment‐induced cardiotoxicity was defined by an absolute decrease in LVEF of ≥10% to below 55% or an absolute decrease of ≥16%. Logistic regression was used to determine the association between candidate risk factors and treatment‐induced cardiotoxicity. Results: Among 573 patients, 92 (16%) developed treatment‐induced cardiotoxicity. Trastuzumab was continued without interruption in 31 of 92 patients with treatment‐induced cardiotoxicity—all were asymptomatic with LVEF of ≥50% at cardiotoxicity diagnosis with median LVEF of 53% (range, 50%–63%), and none developed heart failure during follow‐up. Risk factors associated with treatment‐induced cardiotoxicity included age ( p = .011), anthracycline chemotherapy ( p = .002), and lower pretrastuzumab LVEF ( p
From the most popular Breast Cancer Treatment Books, Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction is the one of great book to have. You can get ebook from:
There are so many ebooks about Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction that are available to have. Thinking of having Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction ebook? You are in the right place. Get the ebook Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction by: .
- Book was ranked at 31 by Google Books for Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction
- Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction published by since 2015 with ISBNs. The book ISBN 13 Code is and ISBN 10 Code is
- Reading Mode in Text Status is false and Reading Mode in Image Status is false
- The book has " Pages" is Printed at BOOK under Category
- Rated by Raters and have average rate at ""
- eBook Maturity (Adult Book) status is NOT_MATURE
- eBook written in en
- Book Preview Address: http://books.google.com/books?id=TNrPvQEACAAJ&dq=Breast+Cancer+Treatment&hl=&cd=310&source=gbs_api
Book Preview
- Server 2: SECURE LINK